Company: TELO
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021496
Chunk: 44

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 8
Chunk 44
---
 activity for the nine months
ended September 30, 2025 and 2024 is summarized below:

 Schedule
of warrant activity

    Weighted  

    Weighted  
    Average  

    Average  
    Remaining  
    Aggregate 

    Number of  
    Exercise  
    Contractual  
    Intrinsic 

    Warrants  
    Price  
    Term (Years)  
    Value 
  
    Outstanding as December 31, 2023 
     2,774,057  
    $4.85  
     4.5(1) 
     - 
  
    Granted 
     50,000  
    $7  
     4.1  
     - 
  
    Outstanding as September 30, 2024 
     2,824,057  
    $4.89  
     4.25  
     - 

    Outstanding as December 31, 2024 
     2,814,057  
    $4.97  
     3.49(2) 
     - 
  
    Granted 
     -  
    $-  
     -  
     - 
  
    Outstanding as of September 30, 2025 
     2,814,057  
    $4.97  
     2.7(2) 
     - 
  
    Exercisable, September 30, 2025 
     2,814,057  
    $4.97  
     2.7(2) 
     - 

    (1)
    The
    warrants herein consist of various contractual terms. The warrants herein consist of 2,429,025 warrants issued to Bay Shore Trust
    that have a remaining contractual term of 4.5 years as of December 31, 2023, and 335,032 warrants issued to investors associated
    with the 2023 Private Placement that currently have an indeterminable contractual term.

    (2)
    The
    warrants herein consist of various contractual terms. The warrants herein consist of 2,429,025 warrants issued to Bay Shore Trust
    that have a remaining contractual term of 2.7 years as of September 30, 2025, 335,032 warrants issued to investors associated with
    the 2023 Private Placement that